Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation
Status:
Enrolling by invitation
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Kidneys retrieved from deceased donors will be randomized for conventional perfusion
(University of Wisconsin: UW) with or without supplementation of thiosulfate, a major H2S
metabolite, and transpl anted thereafter. Recipient's renal function will be assessed
prospectively to determine if thiosulfate improves allograft function.